Sox6 enhances erythroid differentiation in human erythroid progenitors

Area of Science:

• Molecular Biology
• Hematology
• Cell Biology

Background:

• Sox6 is a transcription factor belonging to the Sry (sex-determining region Y)-related high-mobility-group-box family.
• This family of proteins plays a crucial role in specifying cell fates across various cell types.
• The specific role of Sox6 in human erythropoiesis (red blood cell development) was not fully understood.

Purpose of the Study:

• To investigate the function of Sox6 in human erythropoiesis.
• To determine if Sox6 can induce erythroid differentiation.
• To identify direct molecular targets of Sox6 during this process.

Main Methods:

• Overexpression of Sox6 in the K562 erythroleukemic cell line.
• Overexpression of Sox6 in primary erythroid cultures derived from human cord blood CD34+ cells.
• Identification of Sox6 targets using in vitro and in vivo binding assays, focusing on the SOCS3 gene.

Main Results:

• Sox6 overexpression significantly induced erythroid differentiation in both K562 cells and primary erythroid cultures.
• K562 cells showed hemoglobinization and underwent apoptosis (cell death) post-transduction.
• Primary erythroid cultures exhibited accelerated maturation kinetics and increased enucleation rates.
• SOCS3 (suppressor of cytokine signaling-3) was identified as a direct transcriptional target of Sox6.
• Sox6 binds to a conserved regulatory element of the SOCS3 gene, activating its transcription.
• Overexpression of SOCS3 mimicked the growth inhibitory effects of Sox6, confirming it as a key effector.

Conclusions:

• Sox6 plays a critical role in promoting human erythropoiesis and inducing differentiation.
• Sox6 mediates growth inhibition and cell death in erythroid cells, including leukemic K562 cells.
• The identified target SOCS3 is a crucial mediator of Sox6's effects on erythropoiesis and cell growth.